Erlotinib
- Product NDC
- 0093-7664
- 11-digit product format
- 000937664
- Labeler code
- 0093
- Product ID
- 0093-7664_4368f7b2-5bdb-4232-90b0-f6a769d71e9b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Erlotinib
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Application
- ANDA091059
- Marketing category
- ANDA
- Marketing start
- 2019-05-09
- Substance
- ERLOTINIB HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Erlotinib
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ERLOTINIB HYDROCHLORIDE | 150 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | DA87705X9K |
| Rxcui | 603203, 603206, 603208 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0093-7664-56 | Erlotinib | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0093-7664 | ERLOTINIB TABLET, FILM COATED [TEVA PHARMACEUTICALS USA, INC.] | 7 | Current NDC, Legacy NDC, 1 package rows | 20211209_5d97f401-4853-4a9a-907d-21e8a4d16088.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0093-7664-56 | 00093766456 | 30 TABLET, FILM COATED in 1 BOTTLE (0093-7664-56) | 2019-05-09 | 0000-00-00 | No | No | Current |